[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$anab Graphic](https://lunarcrush.com/gi/w:26/t:$anab.png) $anab

AnaptysBio ($ANAB) shares surge following positive rheumatoid arthritis trial data and a company split. Barclays initiates coverage with an Overweight rating and a $XX target.

### About $anab
AnaptysBio, Inc. (ANAB) is a biotechnology company focused on developing immunotherapies.  

### Insights [#](/topic/$anab/insights)
- $anab engagements is up XXXXXX% from the previous week.
- $anab posts created is up XXX% from the previous week.

### Engagements: XXX [#](/topic/$anab/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$anab/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$anab/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXX +108%  
**1 Month**: XXXXXX -XX%  
**6 Months**: XXXXXXXXX -XX%  
**1 Year**: XXXXXXXXX +168%  
**1-Year High**: XXXXXX on 2025-02-12  
**1-Year Low**: X on 2025-10-19  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: XX [#](/topic/$anab/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$anab/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$anab/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XXX +465%  
**6 Months**: XXXXX +29%  
**1 Year**: XXXXX +248%  
**1-Year High**: XXX on 2025-10-03  
**1-Year Low**: X on 2025-10-19  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$anab/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$anab/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$anab/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $anab in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XXX +633%  
**6 Months**: XXX +247%  
**1 Year**: XXXXX +379%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-10-19  

The most influential creators that mention $anab in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@pmdawn](/creator/twitter/pmdawn)                   | X    | XXXXX     | X     | XX          |
| [@IllyrianSpartan](/creator/twitter/IllyrianSpartan) | X    | XXXXX     | X     | XX          |
| [@guydroog](/creator/twitter/guydroog)               | X    | XXXXX     | X     | X           |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | X           |
| [@Jokerparabol](/creator/twitter/Jokerparabol)       | X    | XXXXX     | X     | X           |
| [@Biopharma_Watch](/creator/twitter/Biopharma_Watch) | X    | XXXXX     | X     | X           |

[View More](/list/creators/$anab/100)
  
  
### Sentiment: XX% [#](/topic/$anab/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$anab/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$anab/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +7%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2025-01-26  
**1-Year Low**: XX% on 2025-09-10  

**Most Supportive Themes**
- **Company Split and Buyback:** (40%) Positive sentiment surrounds the announcement of AnaptysBio's split into two companies and a $75M buyback program.
- **Positive RA Trial Data:** (30%) The lead candidate rosnilimab's positive data in rheumatoid arthritis trials is generating excitement.
- **Analyst Upgrades and Price Targets:** (20%) Multiple analysts have raised price targets for $ANAB, indicating confidence in the stock's potential.
  
**Most Critical Themes**
- **Market Competition:** (10%)  Concerns exist regarding the competitive landscape of the RA treatment market.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | XX       | X% | XXX     | XX% | XX       | X% |
|         |          |    |         |     |          |    |
| Total   | XX       | X% | XXX     | XX% | XX       | X% |
  


**Top assets mentioned**
In the posts about $anab in the last XX hours

[Jigstack (STAK2)](/topic/jigstack)
[Jigstack (STAK2)](/topic/$stak)
[Celldex Therapeutics, Inc (CLDX)](/topic/$cldx)
[Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio)
[Alkermes Inc. plc (ALKS)](/topic/$alks)
[BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Eli Lilly and Company (LLY)](/topic/$lly)
[reAlpha Tech Corp. Common Stock (AIRE)](/topic/$aire)
[ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx)

**Top topics mentioned**
In the posts about $anab in the last XX hours

[coins defi](/topic/coins-defi), [stocks healthcare](/topic/stocks-healthcare), [jigstack](/topic/jigstack), [coins dao](/topic/coins-dao), [$abvx](/topic/$abvx), [$barcl](/topic/$barcl), [$stak](/topic/$stak), [$kavl](/topic/$kavl), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [stocks real estate](/topic/stocks-real-estate), [stocks technology](/topic/stocks-technology), [$cldx](/topic/$cldx), [$agio](/topic/$agio), [$alks](/topic/$alks), [$bbio](/topic/$bbio), [eli lilly](/topic/eli-lilly), [$lly](/topic/$lly), [stocks](/topic/stocks), [$aire](/topic/$aire), [$ibrx](/topic/$ibrx), [$bbai](/topic/$bbai), [$elan](/topic/$elan), [$crsp](/topic/$crsp), [advanced micro devices](/topic/advanced-micro-devices), [stocks financial services](/topic/stocks-financial-services), [investment](/topic/investment), [upside](/topic/upside), [atai life](/topic/atai-life), [$crvs](/topic/$crvs), [$apge](/topic/$apge), [$bhvn](/topic/$bhvn), [$open](/topic/$open), [$ycbd](/topic/$ycbd), [$gran](/topic/$gran), [$sprb](/topic/$sprb), [$cdt](/topic/$cdt), [coins solana ecosystem](/topic/coins-solana-ecosystem), [coins insurance](/topic/coins-insurance), [coins arbitrum](/topic/coins-arbitrum), [coins avalanche](/topic/coins-avalanche), [$pbm](/topic/$pbm), [$fbrx](/topic/$fbrx), [tesla](/topic/tesla), [avis budget group inc](/topic/avis-budget-group-inc), [stocks industrials](/topic/stocks-industrials), [$car](/topic/$car), [$valn](/topic/$valn), [$prok](/topic/$prok), [$tngx](/topic/$tngx), [$sgtm](/topic/$sgtm), [$celg](/topic/$celg), [$exas](/topic/$exas), [$roku](/topic/$roku), [$atch](/topic/$atch), [$oris](/topic/$oris), [$capr](/topic/$capr), [trust in](/topic/trust-in), [a very](/topic/a-very), [coins made in usa](/topic/coins-made-in-usa), [$amd](/topic/$amd), [$an](/topic/$an), [telegram](/topic/telegram), [$imvt](/topic/$imvt), [ab](/topic/ab), [marsh](/topic/marsh), [$nams](/topic/$nams), [$cgtx](/topic/$cgtx), [$crdf](/topic/$crdf), [$dmac](/topic/$dmac), [$ixhl](/topic/$ixhl), [$crdl](/topic/$crdl), [$btai](/topic/$btai), [$entx](/topic/$entx), [$cgem](/topic/$cgem), [$mltx](/topic/$mltx), [$atai](/topic/$atai), [positions](/topic/positions), [$tern](/topic/$tern), [$tars](/topic/$tars), [$cnta](/topic/$cnta), [$dnli](/topic/$dnli), [$lac](/topic/$lac), [$rvyl](/topic/$rvyl), [$litm](/topic/$litm), [$wwr](/topic/$wwr), [$sti](/topic/$sti), [$amt](/topic/$amt), [$cgen](/topic/$cgen), [$rcus](/topic/$rcus), [$bcax](/topic/$bcax), [$mnkd](/topic/$mnkd), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$bg](/topic/$bg), [lm funding](/topic/lm-funding), [$prgo](/topic/$prgo), [$bmrn](/topic/$bmrn), [$mnpr](/topic/$mnpr), [$atyr](/topic/$atyr), [$tssi](/topic/$tssi), [$dpro](/topic/$dpro)

### Top Social Posts [#](/topic/$anab/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

""Shark Tank's Kevin Harrington Interviews $SGTM CEO Tony Raynor: Insights from the Original Shark" $CELG $BIIB $ANAB $EXAS $OSTK $ROKU $EIGR $FLXN $LJPC $PLXP $RARX $SYRS $IBB $XBI $VSTM $CRBP $GILD $AMGN $ABBV $LGND $ALNY $GERN $ALXN $PG $MRK $JNJ"  
[X Link](https://x.com/MoneyMaker0009/status/1978821144066105740) [@MoneyMaker0009](/creator/x/MoneyMaker0009) 2025-10-16T13:51Z XXX followers, XXX engagements


"ANAB - I Have a CakeWhen Can I Eat It Too: ANAB R&D Day Takeaways Wedbush Full report in Telegram (in the header)👆 $ANAB $IMVT $MRNA $ARQT $VTYX $KNSA $INSM $PRAX $RARE $FGEN $GLPG $NBIX $ACAD $VKTX $MOR $ZLAB $EXEL $KPTI $IMCR $ABCL $SWTX $OMGA $RNA $ARCT $ALLK $INZY"  
[X Link](https://x.com/Biobeats99/status/1978596639951446178) [@Biobeats99](/creator/x/Biobeats99) 2025-10-15T22:59Z XXX followers, XXX engagements


"$ANAB Somehow missed my alert on this today to pre-position for a bigger breakout. The monthly rectangle bottom looks incredible"  
[X Link](https://x.com/guydroog/status/1978569735043236165) [@guydroog](/creator/x/guydroog) 2025-10-15T21:12Z 1446 followers, XXX engagements


"$AMD -HSBC raises Advanced Micro Devices target to $XXX from $XXX Buy -Wedbush raises target to $XXX from $XXX Outperform - $AN -Wells Fargo trims AutoNation target to $XXX from $XXX = Weight - $ANAB -Wedbush raises AnaptysBio target to $XX from $XX Outperform -"  
[X Link](https://x.com/MarcJacksonLA/status/1978543844783210858) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-15T19:29Z 7574 followers, XXX engagements